Skip to main content

Hims & Hers Health, Inc.

corporate_fare Company Profile

Hims & Hers Health, Inc.

HIMS·NYSE·Industrial Applications And Services·CIK 0001773751

Hims & Hers Health, Inc., launched in 2017, operates a consumer-focused platform that helps customers meet their health and wellness needs. The company provides a digital platform that includes access to a network of qualified healthcare providers, an electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization features. This platform enables access to treatments for various chronic conditions, such as sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, along with services like comprehensive laboratory testing. Hims & Hers connects patients with licensed healthcare professionals who can prescribe medications, including through personalized treatment plans, with prescriptions fulfilled online by licensed pharmacies. Additionally, the company offers a selection of non-prescription health and wellness products. Through its mobile applications, consumers can access educational programs, wellness content, community support, and other services. Since its founding, Hims & Hers has facilitated over fifty million telehealth consultations, providing access to care in the United States, Canada, the United Kingdom, and the European Union (specifically in Germany, the Republic of Ireland, France, and Spain). The company's strategy focuses on its brand, products and services, technology, and clinical excellence.

Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 44 items for HIMS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-11, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for HIMS spans 10-Q, 8-K.

Recent high-impact activity:

  • Hims Adds Lilly's Zepbound to Platform, Plans New Peptides After Guidance Cut
  • Hims & Hers Cuts 2026 EBITDA Outlook, Q4 Guidance Far Below Consensus; Shares Down 18%
  • Hims Cuts 2026 Outlook After Q3 Revenue Miss, Pivots to Branded Weight-Loss Drugs
  • Hims & Hers Cuts Full-Year Outlook After Surprise Q3 Loss; Q4 Guidance Misses Consensus
  • Hims & Hers 10-Q: $890M Q3 Revenue, $33M Net Loss, $60M FTC Legal Accrual

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.35B
Net Income
$128.37M
Diluted EPS
$0.51
Op. Cash Flow
$300.01M
Free Cash Flow
$57.41M
Gross Profit
$1.73B
Operating Income
$105.61M
Cash & Equivalents
$228.62M
Total Debt
$972.58M
Debt / Equity
1.80×
Net Margin
5.5%
Shares Outstanding
224.96M sh
Source: 10-K · filed 2026-02-23 · accession 0001773751-26-000022

Short Interest & Short Volume

5.84 days to cover

FINRA reported short interest of 51,657,110 shares in HIMS as of the October 30, 2026 settlement, a 3.4% decrease from the prior period — about 5.8 days to cover at its recent average daily volume. On November 20, 2026, 59.6% of HIMS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)51,657,110 shares as of October 30, 2026
Change vs prior period▼ 3.4%
Days to cover5.84 at avg daily volume of 8,842,788
Daily short volume (FINRA facilities)59.6% of 7,455,361 shares on November 20, 2026
5-day average short volume60.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with H →
$15.13 +3.63% today
52-week range · as of 2026-11-09 $13.74 – $42.7
Market cap
$3.42B
Volume
16.1M (1.1× avg)
3-mo avg 14.2M
Live data · 2026-11-22 05:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $15.13 info
Change: -$3.87 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $15.13 info
Change: -$3.71 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $15.13 info
Change: -$7.03 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $15.13 info
Change: -$7.20 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $15.13 info
Change: -$8.26 (-35%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.18
Real-time Price: $15.13 info
Change: -$7.05 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.41
Real-time Price: $15.13 info
Change: -$7.28 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
9
Price at Filing: $22.94
Real-time Price: $15.13 info
Change: -$7.81 (-34%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 1:20 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $23.30
Real-time Price: $15.13 info
Change: -$8.17 (-35%) info
Market Cap: $3.422B info
HIMS
Oct 28, 2026, 1:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $29.30
Real-time Price: $15.13 info
Change: -$14.17 (-48%) info
Market Cap: $3.422B info
HIMS
Oct 15, 2026, 5:38 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $29.13
Real-time Price: $15.13 info
Change: -$14.00 (-48%) info
Market Cap: $3.422B info
HIMS
Sep 02, 2026, 7:40 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $28.60
Real-time Price: $15.13 info
Change: -$13.46 (-47%) info
Market Cap: $3.422B info
HIMS
Aug 31, 2026, 3:00 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.28
Real-time Price: $15.13 info
Change: -$14.14 (-48%) info
Market Cap: $3.422B info
HIMS
Aug 21, 2026, 4:54 PM EDT
Source: Binance News
Importance Score:
7
Price at Filing: $33.73
Real-time Price: $15.13 info
Change: -$18.60 (-55%) info
Market Cap: $3.422B info
HIMS
Aug 10, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.31
Real-time Price: $15.13 info
Change: -$16.18 (-52%) info
Market Cap: $3.422B info
HIMS
Aug 10, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $29.49
Real-time Price: $15.13 info
Change: -$14.36 (-49%) info
Market Cap: $3.422B info
HIMS
Jul 29, 2026, 1:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $26.18
Real-time Price: $15.13 info
Change: -$11.05 (-42%) info
Market Cap: $3.422B info
HIMS
Jul 23, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.48
Real-time Price: $15.13 info
Change: -$18.35 (-55%) info
Market Cap: $3.422B info
HIMS
Jul 17, 2026, 4:17 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $32.62
Real-time Price: $15.13 info
Change: -$17.49 (-54%) info
Market Cap: $3.422B info
HIMS
Jul 01, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.45
Real-time Price: $15.13 info
Change: -$22.32 (-60%) info
Market Cap: $3.422B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets